 The primary purpose of this study is to assess the immune response to vitamin D supplementation at two doses 5,000 IU and 10,000 IU daily in both healthy controls and patients with clinically isolated syndrome compared to placebo. Secondary endpoints include 1 disease outcome in the clinically isolated syndrome in terms of clinical relapses and evidence of new lesions on MRI McDonalds MS, 2 Safety of doses used 